Compare Bintang Samudera Mandiri Lines Tbk (BSML) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bintang Samudera Mandiri Lines Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bintang Samudera Mandiri Lines Tbk trades at Rp520 (market cap 952.87B, 18.7M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Bintang Samudera Mandiri Lines Tbk is the larger of the two by market cap, and Bintang Samudera Mandiri Lines Tbk is more actively traded (18.7M versus 817.3K). Which is the better fit depends on your goals.
| BSML | LABS | |
|---|---|---|
Market Cap | 952.87B | 584.6B |
Volume | 18.7M | 817.3K |
Lot | 187.04K | 8.17K |
Turnover | 9.68B | 120.01M |
Average Price | 517.75 | 146.84 |
Value | 9.68B | 120.01M |
Indicative Equilibrium Price | 520 | 146 |
Indicative Equilibrium Volume | 31 | 59 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bintang Samudera Mandiri Lines Tbk
PT Bintang Samudera Mandiri Lines Tbk (the Company) was established based on Notarial Deed No. 101 of Fransiskus Djoenardi, S.H., dated November 17, 2007. The Company has started its operations since 2017.
Read more on BSML →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
